Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-04T18:26:00.915Z Has data issue: false hasContentIssue false

Chapter 37 - Surgical management of soft tissue sarcoma: histologic type and grade guide surgical planning and integration of multimodality therapy

Published online by Cambridge University Press:  19 October 2016

By
Charlotte Ariyan  and
Samuel Singer
Edited by
Markku Miettinen
Markku Miettinen
Affiliation:
National Cancer Institute, Maryland
Get access
Type
Chapter
Information
Modern Soft Tissue Pathology
Tumors and Non-Neoplastic Conditions
 , pp. 1012 - 1023
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lawrence, W Jr, Donegan, WL, Natarajan, N, et al. Adult soft tissue sarcomas: a pattern of care survey of the American College of Surgeons. Ann Surg 1987;205(4):349–359.Google Scholar
Heslin, MJ, Lewis, JJ, Woodruff, JM, Brennan, MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol 1997;4(5):425–431.Google Scholar
Lewis, JJ, Leung, D, Espat, J, Woodruff, JM, Brennan, MF. Effect of reresection in extremity soft tissue sarcoma. Ann Surg 2000;231(5):655–663.CrossRefGoogle ScholarPubMed
Melendez, M, Brandt, K, Evans, GR. Sciatic nerve reconstruction: limb preservation after sarcoma resection. Ann Plast Surg 2001;46(4):375–381.Google Scholar
Brooks, AD, Gold, JS, Graham, D, et al. Resection of the sciatic, peroneal, or tibial nerves: assessment of functional status. Ann Surg Oncol 2002;9(1):41–47.CrossRefGoogle ScholarPubMed
Saint-Cyr, M, Langstein, HN. Reconstruction of the hand and upper extremity after tumor resection. J Surg Oncol 2006;94(6):490–503.Google Scholar
Baxter, BT, Mahoney, C, Johnson, PJ, et al. Concomitant arterial and venous reconstruction with resection of lower extremity sarcomas. Ann Vasc Surg 2007;21(3):272–279.Google Scholar
Adelani, MA, Holt, GE, Dittus, RS, Passman, MA, Schwartz, HS. Revascularization after segmental resection of lower extremity soft tissue sarcomas. J Surg Oncol 2007; 95(6):455–460.Google Scholar
Ghert, MA, Davis, AM, Griffin, AM, et al. The surgical and functional outcome of limb-salvage surgery with vascular reconstruction for soft tissue sarcoma of the extremity. Ann Surg Oncol 2005;12(12):1102–1110.CrossRefGoogle ScholarPubMed
Ariyan, S. The functional pectoralis major musculocutaneous island flap for head and neck reconstruction. Plast Reconstr Surg 1990;86(4):807–808.Google Scholar
Ross, DA, Hundal, JS, Son, YH, et al. Microsurgical free flap reconstruction outcomes in head and neck cancer patients after surgical extirpation and intraoperative brachytherapy. Laryngoscope 2004;114(7):1170–1176.Google Scholar
Duman, H, Evans, GR, Reece, G, et al. Brachytherapy: reconstructive options and the role of plastic surgery. Ann Plast Surg 2000;45(5):477–480.CrossRefGoogle ScholarPubMed
Bui, DT, Cordeiro, PG, Hu, QY, et al. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 2007;119(7):2092–2100.Google Scholar
Kooby, DA, Antonescu, CR, Brennan, MF, Singer, S. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol 2004;11(1):78–84.Google Scholar
Bowne, WB, Antonescu, CR, Leung, DH, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 2000;88(12):2711–2720.Google Scholar
Merchant, NB, Lewis, JJ, Woodruff, JM, Leung, DH, Brennan, MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 1999;86(10):2045–2052.Google Scholar
Rosenberg, SA, Tepper, J, Glatstein, E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196(3):305–315.Google Scholar
Williard, WC, Hajdu, SI, Casper, ES, Brennan, MF. Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann Surg 1992;215(3):269–275.Google Scholar
Pisters, PW, Harrison, LB, Leung, DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14(3):859–868.Google Scholar
O’Sullivan, B, Davis, AM, Turcotte, R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359(9325):2235–2241.Google Scholar
Yang, JC, Chang, AE, Baker, AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16(1):197–203.Google Scholar
Baldini, EH, Goldberg, J, Jenner, C, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 1999;17(10):3252–3259.CrossRefGoogle ScholarPubMed
Lin, PP, Schupak, KD, Boland, PJ, Brennan, MF, Healey, JH. Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer 1998;82(12):2356–2365.Google Scholar
Alektiar, KM, Hong, L, Brennan, MF, Della-Biancia, C, Singer, S. Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results. Int J Radiat Oncol Biol Phys 2007;68(2):458–464.Google Scholar
Rosenberg, SA, Tepper, J, Glatstein, E, et al. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 1983;52(3):424–434.Google Scholar
Chang, AE, Kinsella, T, Glatstein, E, et al. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol 1988;6(9):1491–1500.Google Scholar
Sarcoma Meta-Analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997;350(9092):1647–1654.Google Scholar
Elias, A, Ryan, L, Sulkes, A, et al. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol 1989;7(9):1208–1216.Google Scholar
Elias, AD, Eder, JP, Shea, T, et al. High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol 1990;8(1):170–178.CrossRefGoogle ScholarPubMed
Antman, KH, Elias, A, Ryan, L. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules. Semin Oncol 1990;17(2 Suppl 4):68–73.Google Scholar
Frustaci, S, Gherlinzoni, F, De Paoli, A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001;19(5):1238–1247.Google Scholar
Frustaci, S, De Paoli, A, Bidoli, E, et al. Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 2003;65(Suppl 2):80–84.Google Scholar
Grobmyer, SR, Maki, RG, Demetri, GD, et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 2004;15(11):1667–1672.Google Scholar
Chang, HR, Hajdu, SI, Collin, C, Brennan, MF. The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer 1989;64(7):1514–1520.Google Scholar
Gebhard, S, Coindre, JM, Michels, JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 2002;26(5):601–616.CrossRefGoogle Scholar
Antonescu, CR, Tschernyavsky, SJ, Decuseara, R, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001;7(12):3977–3987.Google Scholar
McCormick, D, Mentzel, T, Beham, A, Fletcher, CD. Dedifferentiated liposarcoma: clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 1994;18(12):1213–1223.Google Scholar
Henricks, WH, Chu, YC, Goldblum, JR, Weiss, SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 1997;21(3):271–281.Google Scholar
Eilber, FC, Eilber, FR, Eckardt, J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 2004;240(4):686–695; discussion 695–697.Google Scholar
Lewis, JJ, Antonescu, CR, Leung, DH, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000;18(10):2087–2094.Google Scholar
Eilber, FC, Brennan, MF, Eilber, FR, et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007;246(1):105–113.Google Scholar
Mentzel, T, Calonje, E, Wadden, C, et al. Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996;20(4):391–405.Google Scholar
Angervall, L, Kindblom, LG, Merck, C. Myxofibrosarcoma: a study of 30 cases. Acta Pathol Microbiol Scand A 1977;85A(2):127–140.Google Scholar
Huang, HY, Lal, P, Qin, J, Brennan, MF, Antonescu, CR. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol 2004;35(5):612–621.Google Scholar
Waters, B, Panicek, DM, Lefkowitz, RA, et al. Low-grade myxofibrosarcoma: CT and MRI patterns in recurrent disease. AJR Am J Roentgenol 2007;188(2):W193–W198.Google Scholar
Mundt, KA, Dell, LD, Austin, RP, et al. Historical cohort study of 10 109 men in the North American vinyl chloride industry, 1942–72: update of cancer mortality to 31 December 1995. Occup Environ Med 2000;57(11):774–781.Google Scholar
Lee, FI, Smith, PM, Bennett, B, Williams, DM. Occupationally related angiosarcoma of the liver in the United Kingdom 1972–1994. Gut 1996;39(2):312–318.Google Scholar
Strobbe, LJ, Peterse, HL, van Tinteren, H, Wijnmaalen, A, Rutgers, EJ. Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome: an unforseen sequela. Breast Cancer Res Treat 1998;47(2):101–109.Google Scholar
Cha, C, Antonescu, CR, Quan, ML, Maru, S, Brennan, MF. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg 2004;239(6):903–909; discussion 909–910.Google Scholar
Stewart, FW, Treves, N. Classics in oncology: lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. CA Cancer J Clin 1981;31(5):284–299.Google Scholar
Naka, N, Ohsawa, M, Tomita, Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 1996;61(3):170–176.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Skubitz, KM, Haddad, PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 2005;104(2):361–366.CrossRefGoogle ScholarPubMed
Fata, F, O’Reilly, E, Ilson, D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999;86(10):2034–2037.Google Scholar
Vauthey, JN, Woodruff, JM, Brennan, MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol 1995;2(2):126–131.CrossRefGoogle Scholar
Grier, HE, Krailo, MD, Tarbell, NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348(8):694–701.Google Scholar
Linet, MS, Ries, LA, Smith, MA, Tarone, RE, Devesa, SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999;91(12):1051–1058.CrossRefGoogle ScholarPubMed
Paulino, AC, Okcu, MF. Rhabdomyosarcoma. Curr Probl Cancer 2008;32(1):7–34.Google Scholar
Lewis, JJ, Leung, D, Woodruff, JM, Brennan, MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228(3):355–365.CrossRefGoogle ScholarPubMed
Singer, S, Antonescu, CR, Riedel, E, Brennan, MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003;238(3):358–370; discussion 370–371.Google Scholar
Fabre-Guillevin, E, Coindre, JM, Somerhausen Nde, S, et al. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Cancer 2006;106(12):2725–2733.Google Scholar
Karakousis, CP, Velez, AF, Gerstenbluth, R, Driscoll, DL. Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol 1996;3(2):150–158.Google Scholar
Tepper, JE, Suit, HD, Wood, WC, et al. Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1984;10(6):825–830.Google Scholar
Sindelar, WF, Kinsella, TJ, Chen, PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas: final results of a prospective, randomized, clinical trial. Arch Surg 1993;128(4):402–410.Google Scholar
Pawlik, TM, Pisters, PW, Mikula, L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006;13(4):508–517.CrossRefGoogle ScholarPubMed
Dematteo, RP, Gold, JS, Saran, L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008;112(3):608–615.Google Scholar
Raut, CP, DeMatteo, RP. Prognostic factors for primary GIST: prime time for personalized therapy? Ann Surg Oncol 2008;15(1):4–6.Google Scholar
Hirota, S, Isozaki, K, Moriyama, Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279(5350):577–580.Google Scholar
Heinrich, MC, Corless, CL, Demetri, GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21(23):4342–4349.Google Scholar
Antonescu, CR, Sommer, G, Sarran, L, et al. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 2003;9(9):3329–3337.Google Scholar
Heinrich, MC, Corless, CL, Duensing, A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299(5607):708–710.Google Scholar
Dematteo, RP, Owzar, K, Maki, RG, et al. Adjuvant imatinib mesylate increases recurrence-free survival (RFS) in patients with completely localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase III Trial ACOSOG Z9001. Proc Am Soc Clin Oncol 2007;Abstract No(10079).Google Scholar
Verweij, J, Casali, PG, Zalcberg, J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 2004;364(9440):1127–1134.CrossRefGoogle ScholarPubMed
DeMatteo, RP, Maki, RG, Singer, S, et al. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 2007;245(3):347–352.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×